Market Place
Sourcing Support
Scipher Medicine® Launches New Biomarker Discovery Approach
30 Jul 2024 //
BUSINESSWIRE
Scipher Medicine® Showcases New Data at EULAR 2024
13 Jun 2024 //
BUSINESSWIRE
Dr. Reginald Seeto Appointed Scipher Medicine CEO, President
09 May 2024 //
BUSINESSWIRE
Scipher Medicine Receives Medicare Coverage for PrismRA® Test
07 Sep 2023 //
BUSINESSWIRE
Scipher Medicine Signs Multi-Target Partnership with Ionis
17 Jul 2023 //
BUSINESSWIRE
Scipher Medicine Publishes New Data Supporting Utility of PrismRA Blood Test
28 Apr 2022 //
BUSINESSWIRE
Scipher Medicine to Participate in Truist Securities Life Sciences AI Symposium
28 Feb 2022 //
BUSINESSWIRE
Scipher Medicine Closes $110 Million Financing
24 Feb 2022 //
BUSINESSWIRE
Scipher Medicine’s blood test decodes RA treatment: study
01 Feb 2022 //
FIERCEBIOTECH
Scipher Medicine to Present at 40th Annual J.P. Morgan Healthcare Conference
06 Jan 2022 //
BUSINESSWIRE
Scipher Medicine Appoints Sam Asgarian, Chief Medical Officer
16 Nov 2021 //
BUSINESSWIRE
RxParadigm Partners with Scipher Medicine for Rheumatoid Arthritis Care
15 Nov 2021 //
BUSINESSWIRE
Scipher Medicine Welcomes John Strumbos as Chief Financial Officer
22 Sep 2021 //
GLOBENEWSWIRE
Scipher Medicine Welcomes Chip Parkinson as Chief Commercial Officer
20 Sep 2021 //
GLOBENEWSWIRE
Scipher Medicine Announces PrismRA® Met Primary and Secondary Endpoints
24 Jun 2021 //
GLOBENEWSWIRE
Scipher Medicine to expand into autoimmune disease therapeutics
30 Apr 2021 //
PHARMAFILE
Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease
12 Aug 2020 //
GLOBENEWSWIRE
Scipher Medicine Closes Series B Funding Led By Northpond Ventures
19 Dec 2019 //
BUSINESS WIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.